Index by author

October 01, 2023; Volume 90,Issue 10

  1. Sekerak, Richard

    1. Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
      Richard Sekerak, MD, Johanna Ben-Ami Lerner, MD, Pooja Prasad, MD and Megha Prasad, MD
      Cleveland Clinic Journal of Medicine October 2023, 90 (10) 607-609; DOI: https://doi.org/10.3949/ccjm.90a.23004

      These conditions often co-exist and can have complex interactions. The progression of kidney disease increases the risk of major adverse cardiovascular events.

  2. Sen, Ayan

    1. Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?
      Simran Gupta, MD, Ayan Sen, MD and Aman Verma, DO
      Cleveland Clinic Journal of Medicine October 2023, 90 (10) 603-605; DOI: https://doi.org/10.3949/ccjm.90a.23040

      Research and robust data are still lacking regarding use of midodrine in this setting.

  3. Short, Elizabeth J.

    1. In Reply: A new paradigm for adult ADHD
      Michael J. Manos, PhD and Elizabeth J. Short, PhD
      Cleveland Clinic Journal of Medicine October 2023, 90 (10) 593; DOI: https://doi.org/10.3949/ccjm.90c.10003

  4. Skoza, Warren A.

    1. What is the most appropriate management of patients with acute decompensated heart failure who develop in-hospital hypotension?
      Lorenzo Braghieri, MD, Warren A. Skoza, MD, Osamah Z. Badwan, MD and Paulino Alvarez, MD
      Cleveland Clinic Journal of Medicine October 2023, 90 (10) 625-631; DOI: https://doi.org/10.3949/ccjm.90a.22095

      The authors offer a tailored approach to risk-stratification in these patients that focuses on early recognition and management of symptomatic and clinically significant hypotension.

Back to top

In this issue